Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 8/20 | 0.60 |
| ▸ | CTSS | P25774 | 3/20 | 0.52 |
| ▸ | CTSL | P07711 | 2/20 | 0.52 |
| ▸ | CTSB | P07858 | 2/20 | 0.52 |
| ▸ | KYNU | Q16719 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.50 |
| ▸ | PLG | P00747 | 1/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.50 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.50 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.50 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24722342 | 0.91 | ELANE (0.55) | CTSKCTSSCTSLCTSBKYNU | |
| SCHEMBL10706457 | 0.87 | CTSK (0.55) | CTSKCTSSCTSLCTSBKYNU | |
| SCHEMBL12022502 | 0.85 | CTSK (0.60) | CTSKCTSSCTSLCTSBCYP1A2 | |
| SCHEMBL27899929 | 0.85 | CTSK (0.60) | CTSKCTSSCTSLCTSBCYP1A2 | |
| SCHEMBL19036901 | 0.85 | CTSK (0.60) | CTSKCTSSCTSLCTSBCYP1A2 | |
| SCHEMBL11515552 | 0.85 | CTSK (0.63) | CTSKCTSSCTSLCTSBCYP1A2 | |
| SCHEMBL22753446 | 0.85 | CTSK (0.63) | CTSKCTSSCTSLCTSBCYP1A2 | |
| SCHEMBL10612913 | 0.85 | CTSK (0.63) | CTSKCTSSCTSLCTSBCYP1A2 | |
| SCHEMBL14479045 | 0.84 | CTSK (0.57) | CTSKCTSSCTSLCTSBKYNU | |
| SCHEMBL10954146 | 0.83 | CTSK (0.62) | CTSKCTSSCTSLCTSBCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220267699-A1 | PEPTIDE ACETALS FOR STABILISING ENZYMES | BASF SE (DE) | 2022-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220267699-A1 | PEPTIDE ACETALS FOR STABILISING ENZYMES | IDE, PEPD, PREP | CTSK 486/4885CTSS 260/4885CTSL 778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.